Publications : Extending the Cure
| Title |
Date |
Description | |
|---|---|---|---|
 |
January 2012 | ||
 |
October 2011 |
What are the policy options for stimulating antibiotic research and development?
|
|
 |
September 2011 | ||
 |
August 2011 | ||
 |
July 2011 |
Are oral vancomycin sales are a useful
marker for Clostridium difficile activity and what historical changes in
the epidemiology of CDI are associated with changes in oral vancomycin
prescribing?
|
|
 |
July 2011 |
Are the seasonal fluoroquinolone usage
patterns related to the timing of the influenza seasons and what proportion of
use is associated with influenza activity?
|
|
 |
April 2011 |
How to describe the prevalence and
characteristics of antimicrobial stewardship programs (ASPs) in
hospitals across the United States and to describe financial support
provided for these programs?
|
|
 |
February 2011 |
Medical
investigators and decision-makers often rely on administrative codes to gauge
infections rates and outcomes of methicillin-resistant Staphylococcus aureus
(MRSA). One such database is the International Classification of Diseases,
9th Revision, Clinical Modification (ICD-9-CM). Is this...
|
|
 |
February 2011 |
How effective
is education in encouraging antibiotic stewardship in physicians, especially in
the United States?
|
|
 |
January 2011 |
What are the incentives of countries to invest in disease surveillance and to
report outbreaks to international health authorities?
|
